![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
https://orcid.org/0000-0002-4717-4513
References
- Alder E. 1998. The Blatt-Kupperman Menopausal Index: a critique. Maturitas 29:19–24.
- Canário ACG, Cabral PUL, Paiva LC, Florencio GLD, Spyrides MH, Gonçalves AKS. 2016. Physical activity, fatigue and quality of life in breast cancer patients. Revista da Associação Médica Brasileira 62:38–44.
- Cornell LF, Mussallem DM, Gibson TC, Diehl NN, Bagaria SP, McLaughlin SA. 2017. Trends in sexual function after breast cancer surgery. Annals of Surgical Oncology 24:2526–2538.
- Couzi RJ, Helzlsouer KJ, Fetting JH. 1995. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. Journal of Clinical Oncology 13:2737–2744.
- Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, et al. 2011. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomized trials. Lancet 378:771–784.
- Eden J. 2016. Endocrine dilemma: managing menopausal symptoms after breast cancer. European Journal of Endocrinology 174:R71–R77.
- [ESCOP Monographs] ESCOP Monographs – Scientific Foundation for Herbal Medicinal Products. 2003. Cimicifugae rhizoma – black cohosh. 2nd ed. Stuttgart, Germany: Georg Thieme-Verlag; p. 567.
- Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, et al. 2006. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9:49–58.
- [INCA] Instituto Nacional de Cancer. 2019. Câncer de Mama [cited 2019 May 26]. Available from: https://www.inca.gov.br/tipos-de-cancer/cancer-de-mama
- Lopes CMC, Lima SMRR, Veiga ECA, Soares JM, Jr., Baracat EC. 2019. Phytotherapeutic medicines: reality or myth? Revista da Associacao Medica Brasileira (1992) 65:292–294.
- Macruz CF, Lima SMRR, Postigo S, Martins MM, Lucarelli AP, de Oliveira VM. 2020. Quality of life and climacteric symptoms in postmenopausal women receiving hormone therapy for breast cancer. Journal of Obstetrics and Gynaecology Canada 42:1243–1247.
- Mollá MDJ, García-Sánchez Y, Sarri AR, Pérez-López FR. 2009. Cimicifuga racemosa treatment and health related quality of life in post-menopausal Spanish women. Gynecological Endocrinology 25:21–26.
- Oliveira LJ, Oliveira HR, Botogoski SR. 2009. Câncer de mama. In: Lima SMRR, Botogoski SR, editors. Menopausa, o que você precisa saber. São Paulo: Atheneu. p. 289–294.
- Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Zepelin HHH. 2005. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstetrics & Gynecology 105:1074–1083.
- Rostock M, Fischer J, Mumm A, Stammwitz U, Saller R, Bartsch HH. 2011. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints – a prospective observational study. Gynecological Endocrinology 27:844–848.
- Rozenberg S, Vandromme J, Antoine C. 2013. Postmenopausal hormone therapy: risks and benefits. Nature Reviews Endocrinology 9:216–227.
- Ruan X, Mueck AO, Beer AM, Naser B, Pickartz S. 2019. Benefit–risk profile of black cohosh (isopropanolic Cimicifuga racemosa extract) with and without St John’s wort in breast cancer patients. Climacteric 22:339–347.
- Utian WH. 2004. Menopause-related definitions. International Congress Series 1266:133–138.
- Wiegel M, Meston C, Rosen R. 2005. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. Journal of Sex & Marital Therapy 31:1–20.
- Yurek D, Farrar W, Andersen BL. 2000. Breast cancer surgery: comparing surgical groups and determining individual differences in postoperative sexuality body change stress. Journal of Consulting and Clinical Psychology 68:697–709.